Ingmar Rompen

37 posts

Ingmar Rompen

Ingmar Rompen

@IngmarFRompen

Surgeon

Katılım Şubat 2023
36 Takip Edilen50 Takipçiler
Ingmar Rompen
Ingmar Rompen@IngmarFRompen·
Postpancreatectomy hemorrhage 🩸 Our comprehensive paper on a serious complication occurring in 5.9% of patients and associated with a 10 fold increase in mortality. @ThomasHankMD @surgery_hps
Giovanni Marchegiani@Gio_Marchegiani

Postpancreatectomy 🩸 hemorrhage: risk factors and outcomes 🔎 10k pts 🆎 PPH 6% / motality 3% bothe increasing with complexity PPH increased 🔟 fold mortality especially if 🔪 relaparotomy 🌱 bleeding from HA / SMA ⏱️ late bleeding journals.lww.com/annalsofsurger…

English
0
0
5
125
Ingmar Rompen retweetledi
Annals of Surgery
Annals of Surgery@AnnalsofSurgery·
In IPMN-derived pancreatic ductal adenocarcinoma, a minimum of 10 lymph nodes should be harvested, and the optimal number to maximize survival is 20 lymph nodes. journals.lww.com/annalsofsurger…
Annals of Surgery tweet media
English
0
24
51
13.9K
Ingmar Rompen
Ingmar Rompen@IngmarFRompen·
Improved outcomes after merger of two university medical centers to form a very high volume center (133 Whipples per year). Description of evidence-based treatment protocols and merging process within the manuscript.
Marc Besselink@MarcBesselink

What happens when you merge two high volume centers for #pancreas #surgery? Birth of @amsterdamumc ❌❌❌ 😃 500 vs 500 Whipples (pre-vs post merger) ✅ 30-day mortality: 2.0 to 0.4%, P=0.02 ✅ failure-to-rescue: 4.9 to 1.1%, P=0.04 ✅ major morbidity: 41 to 35%, P=0.037 ✅ POPF grade C: 2.4 to 0.8%, P=0.044 ✅ PPH grade B/C: 8.0 to 4.6%, P=0.027 Outcomes improved for both centers. Higher volume with quality program pays off ⏩️journals.lww.com/annalsofsurger…

English
0
0
4
225
Ingmar Rompen retweetledi
Annals of Surgery
Annals of Surgery@AnnalsofSurgery·
IPMN surveillance doesn’t just catch cyst changes—it helps detect other cancers earlier. This study found improved stage at diagnosis and survival in monitored patients. journals.lww.com/annalsofsurger…
English
1
19
44
5.1K
Ingmar Rompen retweetledi
IHPBA
IHPBA@IHPBA·
We are saddened by the sudden passing of Dr. Sean Cleary. Sean was an exceptional surgeon, a visionary leader, and above all, a generous and caring human being. We extend our heartfelt condolences to his wife Janice, his sons Christian and Owen, and all who knew and loved him.
AHPBA@AHPBA

AHPBA honors the life and legacy of Dr. Sean P. Cleary - leader, mentor, colleague, friend. Dr. Cleary changed AHPBA, and all who knew him, for the better. Read tribute: cvent.me/aaB9bq

English
6
11
54
7.1K
Ingmar Rompen
Ingmar Rompen@IngmarFRompen·
See our nationwide analysis on the stages of pancreatic cancer at diagnosis: - 57.5% metastatic - 10.9% LAPC - 8.2% borderline resectable - 23.4% resectable True reference as vascular contact was analyzed for >16’000 patients, no center selection. @TFStoop @MarcBesselink
BJS@BJSurgery

Resectability stages of pancreatic cancer: nationwide reference ➡️ doi.org/10.1093/bjs/zn… This population-based study on the NCCN resectability stages of pancreatic adenocarcinoma indicates that the rate of LAPC was lower than reported in literature, whereas the rate of PRPC is higher This is the first study based on a nationwide registry that reports the distribution of the anatomical resectability stages among all-comers with pancreatic adenocarcinoma and may serve as a reference for future literature and study desig Work by Thomas F Stoop , Ingmar F Rompen , Mahsoem Ali , Bas Groot Koerkamp , Bert A Bonsing , Jan Willem B de Groot , Geert A Cirkel , Hjalmar C van Santvoort , Inez M Verpalen , I Quintus Molenaar , Johanna W Wilmink , Judith de Vos-Geelen , Lois A Daamen , Marc R W , Marjolein Y V Homs , Martijn P W Intven , Martijn W J Stommel , Vincent E de Meijer , Lydia G van der Geest , Marc G Besselink , Dutch Pancreatic Cancer Group #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma

English
2
1
8
540
Ingmar Rompen retweetledi
Annals of Surgery
Annals of Surgery@AnnalsofSurgery·
📊 Smarter stratification for pancreatic cancer care: This multicenter study validated the PANAMA score to predict both survival and who should get chemo after FOLFIRINOX and surgery. 🔗journals.lww.com/annalsofsurger…
English
0
8
23
2.7K
Ingmar Rompen retweetledi
Giovanni Marchegiani
Giovanni Marchegiani@Gio_Marchegiani·
Hora est! 🎓 PhD cerimony in 🇳🇱 is just something different… with two ⭐️⭐️ like @ammar_asrar and Joe Habib then it’s glorious! Thank you for having me in this fantastic IPMN journey between 🇺🇸 and 🇪🇺 Looking forward to the next steps (and to be as tall as @MarcBesselink 😂)
Giovanni Marchegiani tweet mediaGiovanni Marchegiani tweet mediaGiovanni Marchegiani tweet media
English
5
4
56
3.4K
Ingmar Rompen retweetledi
Annals of Surgery
Annals of Surgery@AnnalsofSurgery·
Pancreatic cancer patients aren't all the same. 🧬 The PANAMA score identifies who really benefits from post-op chemo after FOLFIRINOX—saving some from unnecessary treatment. 🔗journals.lww.com/annalsofsurger…
English
0
21
58
6.3K
Ingmar Rompen retweetledi
Hiroyuki Ishida
Hiroyuki Ishida@Hiro_Ishida_MD·
Published in @hpbjournal, our 🌎 survey study on surgical management of pancreatic neck/body cancer with venous involvement 🔍: 📝 222 surgeons, 49 countries, 6 continents 📍 Heterogenity in surgical management strategies ⚠️ Need for prospective studies & guidelines
Hiroyuki Ishida tweet mediaHiroyuki Ishida tweet media
English
2
37
132
13.3K
Ingmar Rompen retweetledi
Giovanni Marchegiani
Giovanni Marchegiani@Gio_Marchegiani·
Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 🌎 1k resected only 7% after NAT 👍 BR / LAPC no worse OS after NAT 🧪 CA19.9 indicates “biological” treatment effect 👉journals.lww.com/annalsofsurger…
Giovanni Marchegiani tweet mediaGiovanni Marchegiani tweet mediaGiovanni Marchegiani tweet media
English
0
27
74
8.5K
Ingmar Rompen retweetledi
JAMA Surgery
JAMA Surgery@JAMASurgery·
Early surgery results in better pain relief, higher patient satisfaction, and fewer reinterventions compared to an endoscopy-first approach for patients with painful chronic pancreatitis with dilated pancreatic duct. ja.ma/4i221at
JAMA Surgery tweet media
English
0
15
29
5.2K
Ingmar Rompen retweetledi
Giovanni Marchegiani
Giovanni Marchegiani@Gio_Marchegiani·
⏰ Temporary Portal Vein Bypass for Resection of Pancreatic Neoplasms 🇩🇪 63 consecutive LAPC cases 🚨 Severe complications 25% / No liver failure / mortality 6% 👷‍♀️Decision according to anatomy + extent arterial involvement 🫵 Your practice?! journals.lww.com/annalsofsurger…
Giovanni Marchegiani tweet media
GIF
Giovanni Marchegiani tweet media
English
1
27
92
15K
Ingmar Rompen retweetledi
Thomas Stoop
Thomas Stoop@TFStoop·
PVR 1-2 vs 3-4 during pancreatoduodenectomy for resectable #PDAC with venous involvement? In @AnnalsofSurgery our observational study with 357 patients🇸🇪🇯🇵🇳🇱🇺🇸: 📌PVR type NOT associated with OS, locoregional recurrence & major morbidity ➡️ surgeon’s personal preference
Thomas Stoop tweet media
English
1
8
24
2.2K

Keşfet

@ThomasHankMD @surgery_hps @TFStoop @MarcBesselink @IHPBA @EurPancClub @EAHPBA @OncoAlert